Abstract
Leukemia is a clonal disease secondary to malignant transformation of one or more normal hematopoietic stem cells. These leukemic stem cells are capable of proliferation and self renewal. They give rise to one or more dominant clones of cells that eventually fill the bone marrow and suppress normal hematopoiesis in the patient. At this time clinical disease becomes apparent with signs and symptoms of marrow failure. The population of blasts in acute leukemia contains cells capable of colony formation in culture [1–6]. These cells are called leukemic colony forming units, L-CFU. If the colonies are harvested from culture and replated, some also contain cells capable of forming colonies so that proliferation of stem cells capable of self renewal can be demonstrated. There is substantial evidence that L-CFU which replicate extensively in vitro and form large colonies are identical or closely related to the leukemic stem cell responsible for maintenance of the leukemic clone in the patient [7, 8].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Robinson WA, Kurnick JE, Pike BL: Colony growth of human leukemic peripheral blood cells in vitro. Blood 38:500–508, 1971.
Buick RN, Till JE, McCulloch EA: Colony assay for proliferative blast cells circulating in myeloblastic leukaemia. Lancet 1:862–963, 1977.
Moore MAS, Spitzer G, Williams N, Metcalf D, Buckley J: Agar culture studies in 127 cases of untreated acute leukemia: The prognostic value of reclassification of leukemia according to in vitro growth cheracteristics. Blood 44:1–18, 1974.
Dicke KA, Spitzer G, Ahearn MJ: Colony formation in vitro by leukaemic cells in acute myelogenous leukaemia with phytohaemagglutinin as stimulating factor. Nature 259: 129–130, 1976.
Smith SD, Uyeki EM, Lowman JT: Colony formation in vitro by leukemic cells in acute lymphoblastic leukemia (ALL). Blood 52:712–718, 1978.
Izaguirre CA, Curtis J, Messner H, McCulloch EA: A colony assay for blast cell progenitors in non-B non T (common) acute lymphoblastic leukemia. Blood 57:823–829, 1981.
McCulloch EA, Till JE: Blast cells in acute myeloblastic leukemia: A model. Blood Cells 7:63–77, 1981.
McCulloch EA: Stem cells in normal and leukemic hemopoiesis. Blood 62:1–13, 1983).
Salmon SE, Hamburger AW, Soehnlen B, Durie BGM, Alberts DS, Moon TE: Quantitation of differential sensitivity of human-tumor stem cells to anti-cancer drugs. N Engl J Med 298:1321–1327, 1978.
Von Hoff DD, Cowan J, Harris G, Reisdorf G: Human tumor cloning: feasibility and clinical correlations. Can Chemo Pharm 6:265–271, 1981.
Selby P, Buick R, Tannock I: A critical appraisal of the ‘human tumor stem-cell assay’. N Engl J Med 308:129–134, 1983, 1983.
Minden MD, Buick RN, McCulloch EA: Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia. Blood 54:186–195, 1979.
Merchant RE, Hofmann V: Human clonogenic cells in vitro: Improved preparatory techniques for the collection and concentration of leukemic colonies from methylcellulose cultures for morphologic, Cytokinetic, and histochemical evaluation. Stem Cells 2:155–163, 1982.
Ozawa K, Hashimoto Y, Urabe A, Suda T, Motoyoshi K, Takaku F, Miura Y: A new method for permanent preparations of hemopoietic cells cultured in methylcellulose medium. Exp Hematol 10:145–150, 1982.
Trent JM, Davis JR, Durie BGM: Cytogenetic analysis of leukaemic colonies from acute and chronic myelogenous leukaemia. Br J Cancer 47:103–109, 1983.
Till JE, McCulloch EA: Hemppoietic stem cell differentiation. Biochim Biophys Acta 605:431–459, 1980.
Francis GE, Berney JJ, Bodger MP, Bol SJL, Wing MA, Hoffbrand AV: Clone size potential and sensitivity to colony-stimulating activity: differentiation-linked properties of granulocyte-macrophage progenitor cells. Stem Cells 1:124–139, 1981.
Preisler HD: An integrated approach to the study and treatment of acute myelocytic leukemia. In: Adult leukemias 1, Bloomfield CD (ed). The Hague. Martinus Nijhoff Publishers, 1982, pp 155–197.
Mackillop WJ, Ciampi A, Till JE, Buick RN: A stem cell model of human tumor growth: implications for tumor cell clonogenic assays. J Natl Cancer Inst 70:9–16, 1983.
Buick RN, Minden MD, McCulloch EA: Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. Blood 54:95–104, 1979.
Buick RN, Chang LJ-A, Messner HA, Curtis JE, McCulloch EA: Self-renewal capacity of leukemic blast progenitor cells. Cancer Res 41:4849–4852, 1981.
Buick RN, Izaguirre CA, McCulloch EA: Self-renewal of leukemic blast progenitors as a target for therapeutic intervention. In: Maturation factors and cancer, Moore MAS (ed). New York, Raven Press, 1982, pp 293–298.
Burgess AW, Metcalf D: The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56:947–958, 1980.
Burgess AW, Wilson EMA, Metcalf D: Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. Blood 49:573–583, 1977.
DiPesio JF, Brennan JK, Lichtman MA, Abboud CN, Kirkpatrick FH: The fractionation, characterization and subcellular localization of colony stimulating activities released by the human monocyte-like cell line GCT. Blood 56:717–727, 1980.
Francis GE, Berney JJ, Tuma GA, Wing MA, Hoffbrand AV: Divergent sensitivities of leukaemic cells to human placental conditioned medium and leucocyte feeder layers. Leuk Res 4:531–536, 1980.
Swart K, Hagemeijer A, Lowenberg B: Acute myeloid leukemia colony growth in vitro: Differences of colony forming cells in PHA-supplemented and standard leukocyte feeder cultures. Blood 59:816–821, 1982.
Taetle R, Caviles A, Koziol J: Response of human myeloid leukemia cells to various sources of colony stimulating activity and phytohemagglutinin conditioned medium. Cancer Res 43:2350–2357, 1983.
Park CH, Savin MA, Hoogstraten, Amare M, Hathaway P: Improved growth of in vitro colonies in human acute leukemia with the feeding culture method. Cancer Res 37:4595–4601, 1977.
Park CH: Cell-cycle manipulation of human leukemic progenitor cells with humoral adjustments in vitro. Blood 58:179–182, 1981.
Smith SD, Trueworthy RC, Kisker SE, Noller LG, Lowman JT: In vitro sensitivity of normal granulocytic and lymphoma colonies to vinca alkaloids. Cancer 51:417–422, 1983.
Izaguirre CA, Minden MD, Howatson AF, McCulloch EA: Colony formation by normal and malignant human B-lymphocytes. Br J Cancer 42:430–437, 1980.
McCulloch EA, Buick RN, Curtis JE, Messner HA, Senn JS: The heritable nature of clonal characteristics in acute myeloblastic leukemia. Blood 58:105–109, 1981.
Wan SH, Huffman DH, Azarnoff DL, Hoogstraten B, Larsen WE: Pharmacokinetics of 1-β-D-arabinosylcytosine in humans. Cancer Res 34:392–397, 1974,
Preisler HD: Treatment failure in AML. Blood Cells 8:585–600, 1982.
Preisler HD: Prediction of response to chemotherapy in acute myelocytic leukemia. Blood 56:361–367, 1980.
Park CH, Amare M, Savin MA, Goodwin JW, Newcomb MM, Hoogstraten B: Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells. Blood 55:595–601, 1980.
Niho Y, Till JE, McCulloch EA: Effect of arabinosyl cytosine on granulopoietic colony formation by marrow cells from leukemic and non-leukemic patients. Exp Hemat 4:63–69, 1976.
Park CH, Wiernik PH, Morrison FS, Amare M, Van Sloten K, Maloney TR: Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs. Cancer Res 43:2346–2349, 1983.
Taetle R, Buick R, McCulloch EA: Effect of interferon on colony formation in culture by blast cell progenitors in acute myeloblastic leukemia. Blood 56:549–552, 1980.
Chang LJ-A, McCulloch EA: Dose-dependent effects of a tumor promotor on blast cell progenitors in human myeloblastic leukemia. Blood 57:361–367, 1981.
Goldie JH, Coldman AJ: A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727–1731, 1979.
Elliot EM, Ling V: Selection and characterization of Chinese hamster ovary cell mutants resistant to melphalan (L-phenylalanine mustard). Cancer Res 41:393–400, 1981.
Ling V, Thompson LH: Reduced permeability in CHO cells as a mechanism of resistance to colchinine. J Cell Phyciol 83:103–116, 1974.
Preisler HD, Reese pa, Marinello MJ, Pothier L: Adverse effects of aneuploidy on the outcome of remission induction therapy for acute nonlymphocytic leukaemia: analysis of types of treatment failure. Brit J Haemat 53:459–466, 1983.
Preisler HD, Azarnia N, Marinello MJ: Growth of leukemic cells in vitro: Relationship to patient and leukemic cell characteristics and to outcome of therapy. Cancer Res 44:1712–1717, 1984.
Preisler HD and 12 others: Prediction of response of patients with acute nonlymphocytic leukemia to remission induction therapy: Use of clinical measurements. Brit J Haemat, 1985.
Spitzer G, Dicke KA, Gehan EA, Smith T, McCredie KB, Barlogie B, Freireich EJ: A simplified in vitro classification for prognosis in adult acute leukemia: The application of in vitro results in remission — predictive models. Blood 48:795–807, 1976.
Francis GE, Tuma GA, Berney JJ, Hoffbrand AV: Sensitivity of acute myeloid leukemia cells to colony stimulating activity: relation to response to chemotherapy. Brit J Haemat 49:259–267, 1981.
Buick RN, Messner HA, Till JE, McCulloch: Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man. J Natl Cancer Inst 62:249–255, 1979.
Howell SB, Taetle R, Mendelsohn J: Thymidine as a chemotherapeutic agent: Sensitivity of normal human marrow, peripheral blood T cells, and acute non-lymphocytic leukemia. Blood 55:505–510, 1980.
Taetle R, Guittard JP, Mendelsohn JM: Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglanding E in chronic myeloproliferative disorders. Exp Hematol 8:1190–1201, 1980.
Taetle R, Acidic isoferritins (leukemia-associated inhibitory activity) fail to inhibit proliferation in acute myelogenous leukemia. Blood 58:653–657, 1981.
McCulloch EA, Curtis JE, Messner HA, Senn JS, Germanson TP: The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). Blood 59:601–608, 1982.
Park CH, Amare M, Morrison FS, Maloney TR, Goodwin JW: Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: Clinical correlations in acute nonymphocytic leukemia. Cancer Treat Rep 66:1257–1261, 1982.
Preisler HD: Therapy for patients with acute myelocytic leukemia who enter remission: bone marrow transplantation or chemotherapy. Cancer Treat Reports 66:1467–1473, 1982.
Taetle R, Guittard JP: Modulation of leukemia blast colony growth by steroid hormones. Brit J Haemat 50:247–255, 1982.
Findley HW, Steuber CP, Ruymann FB, Culbert S, Ragab AH: The effect of retinoic acid on the clonal growth of childhood myeloid and lymphoid leukemias. Experimental Hematology, 1985.
Goldberg J, Zamkoff KW, Nelson DA, Davey FR, Gottlieb AJ: The in vitro effects of vincristine on peripheral blood leukocyte progenitor cells (CFU-C) in patients in blast crisis of chronic granulocytic leukemia: correlation with clinical response. Am J Hemat 14:149–157, 1983.
Taetle R, Richardson D, To D, Royston I, Mendelsohn J: Colony-forming assay for circulating chronic lymphocytic leukemia cells. Leukemia Res 6:335–344, 1982.
Taetle R, To D, Mendelsohn J: In vitro sensitivity to steroid hormones and cytotoxic agents of normal and malignant lymphocytr colony-forming cells. Cancer Res 43:3553–3558, 1983
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Hutton, J.J. (1985). Chemosensitivity of In Vitro Colony Forming Units as a Predictor of Response to Antileukemic Drugs. In: Bloomfield, C.D. (eds) Chronic and Acute Leukemias in Adults. Cancer Treatment and Research, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2581-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2581-9_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9619-5
Online ISBN: 978-1-4613-2581-9
eBook Packages: Springer Book Archive